This is a response to Yang et al on our work entitled ‘Risk-adjusted Outcomes of Clinically RelevantPancreatic Fistula Following Pancreatoduo-denectomy: A Model for Performance Evaluation", mainly centered on the debate whether octreotide is beneficial in preventing pancreatic fistula
Response to: "Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation"
Maggino, Laura;
2018-01-01
Abstract
This is a response to Yang et al on our work entitled ‘Risk-adjusted Outcomes of Clinically RelevantPancreatic Fistula Following Pancreatoduo-denectomy: A Model for Performance Evaluation", mainly centered on the debate whether octreotide is beneficial in preventing pancreatic fistula
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
